First Case of A859T Epidermal Growth Factor Receptor Mutation Responding to Erlotinib

被引：6
|
作者：
Le Maignan, Laureline [1 ]
Mirebeau-Prunier, Delphine [2 ]
Vervueren, Laurent [3 ]
Jeanfaivre, Thierry [1 ]
Urban, Thierry [1 ]
Hureaux, Jose [1 ]
机构：
[1] Acad Hosp, Dept Pulmonol, F-49933 Angers, France
[2] Acad Hosp, Biochem & Mol Biol Lab, F-49933 Angers, France
[3] Acad Hosp, Dept Nucl Med, F-49933 Angers, France
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 03期
关键词：
CELL LUNG-CANCER; GEFITINIB; IMPACT;
D O I：
10.1097/JTO.0b013e3182037c0c
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：639 / 640
页数：2
相关论文
共 50 条
  • [1] Clinical Outcomes with Erlotinib in Patients with Epidermal Growth Factor Receptor Mutation
    Mok, Tony S. K.
    D'arcangelo, Manolo
    Califano, Raffaele
    DRUGS, 2012, 72 : 3 - 10
  • [2] Clinical Outcomes with Erlotinib in Patients with Epidermal Growth Factor Receptor Mutation
    Tony S. K. Mok
    Manolo D’arcangelo
    Raffaele Califano
    Drugs, 2012, 72 : 3 - 10
  • [3] Tuberculosis in epidermal growth factor receptor mutation in lung adenocarcinoma on treatment with gefitinib/erlotinib
    Gothi, D.
    Spalgais, S.
    INDIAN JOURNAL OF CANCER, 2017, 54 (01) : 1 - 1
  • [4] Epidermal growth factor receptor mutation heterogeneity analysis of pulmonary sarcomatoid carcinoma successfully treated with erlotinib: A case report
    Zou, Fangwen
    Xie, Guiyuan
    Ma, Jin-An
    Zhou, Dong-Ai
    Jiang, Yi
    Zheng, Jiao-Yun
    ONCOLOGY LETTERS, 2015, 9 (05) : 2239 - 2243
  • [5] A Novel Insertion Mutation on Exon 20 of Epidermal Growth Factor Receptor, Conferring Resistance to Erlotinib
    Khan, Nawazish A.
    Mirshahidi, Saied
    Mirshahidi, Hamid R.
    CASE REPORTS IN ONCOLOGY, 2014, 7 (02): : 491 - 496
  • [6] Two Cases of Psoriasis Responding to Erlotinib: Time to Revisiting Inhibition of Epidermal Growth Factor Receptor in Psoriasis Therapy?
    Overbeck, Tobias R.
    Griesinger, Frank
    DERMATOLOGY, 2012, 225 (02) : 179 - 182
  • [7] Epidermal growth factor receptor-activating mutation(E746_T751>VP) in pancreatic ductal adenocarcinoma responds to erlotinib, followed by epidermal growth factor receptor resistance-mediating mutation (A647T): A case report and literature review
    Patel, Girijesh Kumar
    Perry, Josiah B.
    Abdul-Rahim, Osama
    Frankel, Arthur E.
    Cameron, Daniel
    Taylor, William
    Rocconi, Rodney P.
    Abushahin, Laith
    Nelson, Cindy
    Singh, Ajay P.
    Khushman, Moh'd
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2020, 16 (04) : 950 - +
  • [8] A Case of Anaplastic Cancer with Somatic Mutation of Epidermal Growth Factor Receptor
    Rhee, Sang Youl
    Park, Min A.
    Byun, Jong Kyu
    Kim, Yu Jin
    Hong, Soo Min
    Park, So Young
    Chin, Sang Ouk
    Maeng, Chi Hoon
    Eun, Young Gyu
    Park, Bong Jin
    Kim, Youn Wha
    Kim, Tae-Hyung
    Choi, Hyung Jin
    Kim, Joo Young
    Oh, Seungjoon
    Kim, Sung-Woon
    Woo, Jeong-taek
    Kim, Young Seol
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [9] Response to Erlotinib in Metastatic Lung Adenocarcinoma with a Rare Double Epidermal Growth Factor Receptor (EGFR) Mutation
    Jafri, Syed H. R.
    Blanco, Angel
    Labdi, Bonnie A.
    Guo, Shan
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S410 - S410
  • [10] Epidermal Growth Factor Receptor Mutation and Chemosensitivity
    Matsubara, Daisuke
    Niki, Toshiro
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (04) : 771 - 772
12345